Paul T. Wingfield
#151,127
Most Influential Person Now
Researcher
Paul T. Wingfield's AcademicInfluence.com Rankings
Paul T. Wingfieldcomputer-science Degrees
Computer Science
#7961
World Rank
#8377
Historical Rank
Machine Learning
#3126
World Rank
#3165
Historical Rank
Artificial Intelligence
#3425
World Rank
#3475
Historical Rank
Database
#5014
World Rank
#5208
Historical Rank

Download Badge
Computer Science
Paul T. Wingfield's Degrees
- PhD Computer Science University of California, Berkeley
- Masters Computer Science Stanford University
Similar Degrees You Can Earn
Why Is Paul T. Wingfield Influential?
(Suggest an Edit or Addition)Paul T. Wingfield's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Activated STING in a vascular and pulmonary syndrome. (2014) (903)
- Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation (1993) (855)
- Overcoming the overlap problem in the assignment of 1H NMR spectra of larger proteins by use of three-dimensional heteronuclear 1H-15N Hartmann-Hahn-multiple quantum coherence and nuclear Overhauser-multiple quantum coherence spectroscopy: application to interleukin 1 beta. (1989) (805)
- A novel, highly stable fold of the immunoglobulin binding domain of streptococcal protein G. (1993) (729)
- Interleukin-35 Induces Regulatory B Cells that Suppress CNS Autoimmune Disease (2014) (571)
- TIMP-2 Mediated Inhibition of Angiogenesis An MMP-Independent Mechanism (2003) (504)
- Three‐dimensional solution structure of the 44 kDa ectodomain of SIV gp41 (1998) (388)
- Analysis of the backbone dynamics of interleukin-1.beta. using two-dimensional inverse detected heteronuclear nitrogen-15-proton NMR spectroscopy (1990) (381)
- The CD4 determinant for downregulation by HIV-1 Nef directly binds to Nef. Mapping of the Nef binding surface by NMR. (1996) (361)
- Domains of the integrase protein of human immunodeficiency virus type 1 responsible for polynucleotidyl transfer and zinc binding. (1993) (342)
- The solution structure of HIV-1 Nef reveals an unexpected fold and permits delineation of the binding surface for the SH3 domain of Hck tyrosine protein kinase (1996) (338)
- Solution NMR of proteins within polyacrylamide gels: Diffusional properties and residual alignment by mechanical stress or embedding of oriented purple membranes (2000) (303)
- Cloning and expression of a cDNA for human thioredoxin. (1988) (233)
- Specific complex of human immunodeficiency virus type 1 rev and nucleolar B23 proteins: dissociation by the Rev response element (1991) (216)
- Flexibility and function in HIV-1 protease (1995) (210)
- Protein precipitation using ammonium sulfate. (2001) (193)
- High-resolution mass spectrometry of viral assemblies: Molecular composition and stability of dimorphic hepatitis B virus capsids (2008) (192)
- Micelle-induced curvature in a water-insoluble HIV-1 Env peptide revealed by NMR dipolar coupling measurement in stretched polyacrylamide gel. (2002) (188)
- Assignment of the side-chain proton and carbon-13 resonances of interleukin-1.beta. using double- and triple-resonance heteronuclear three-dimensional NMR spectroscopy (1990) (174)
- IL-1 enhances expansion, effector function, tissue localization, and memory response of antigen-specific CD8 T cells (2013) (173)
- Refined solution structure and backbone dynamics of HIV‐1 Nef (1997) (162)
- Complete resonance assignment for the polypeptide backbone of interleukin 1 beta using three-dimensional heteronuclear NMR spectroscopy. (1990) (160)
- A powerful method of sequential proton resonance assignment in proteins using relayed 15N‐1H multiple quantum coherence spectroscopy (1989) (156)
- Anisotropic rotational diffusion of perdeuterated HIV protease from 15N NMR relaxation measurements at two magnetic fields (1996) (154)
- High-resolution three-dimensional structure of interleukin 1 beta in solution by three- and four-dimensional nuclear magnetic resonance spectroscopy. (1992) (150)
- Kinetics of folding of the all-beta sheet protein interleukin-1 beta. (1993) (144)
- Analysis of the backbone dynamics of interleukin-1 beta using two-dimensional inverse detected heteronuclear 15N-1H NMR spectroscopy. (1990) (142)
- Solution NMR evidence that the HIV-1 protease catalytic aspartyl groups have different ionization states in the complex formed with the asymmetric drug KNI-272. (1996) (133)
- Overview of the Purification of Recombinant Proteins (2015) (133)
- Implications of the HIV-1 Rev dimer structure at 3.2 Å resolution for multimeric binding to the Rev response element (2010) (132)
- High-resolution three-dimensional structure of reduced recombinant human thioredoxin in solution. (1992) (131)
- Three-dimensional structure of ubiquinol:cytochrome c reductase from Neurospora mitochondria determined by electron microscopy of membrane crystals. (1981) (131)
- Heparin Binding and Oligomerization of Hepatocyte Growth Factor/Scatter Factor Isoforms (1997) (128)
- Identification and localization of bound internal water in the solution structure of interleukin 1.beta. by heteronuclear three-dimensional proton rotating-fram Overhauser nitrogen-15-proton multiple quantum coherence NMR spectroscopy (1990) (127)
- IL-12p35 induces expansion of IL-10 and IL-35-expressing regulatory B cells and ameliorates autoimmune disease (2017) (126)
- Tumour necrosis factor is a compact trimer (1987) (122)
- Structure and dynamics of micelle-associated human immunodeficiency virus gp41 fusion domain. (2005) (117)
- Comparative immunogenicity of hepatitis B virus core and E antigens. (1988) (116)
- NMR and X-ray Evidence That the HIV Protease Catalytic Aspartyl Groups Are Protonated in the Complex Formed by the Protease and a Non-Peptide Cyclic Urea-Based Inhibitor (1994) (115)
- The crystal structure of the SIV gp41 ectodomain at 1.47 A resolution. (1999) (113)
- Stability and shape of hepatitis B virus capsids in vacuo. (2008) (110)
- Preparation and Extraction of Insoluble (Inclusion‐Body) Proteins from Escherichia coli (1995) (110)
- An Unusual Topological Structure of the HIV-1 Rev Response Element (2013) (108)
- Nucleolar protein B23 stimulates nuclear import of the HIV-1 Rev protein and NLS-conjugated albumin. (1997) (107)
- Biophysical and Functional Characterization of Full-length, Recombinant Human Tissue Inhibitor of Metalloproteinases-2 (TIMP-2) Produced in Escherichia coli (1999) (107)
- Purification and characterization of human interleukin‐1β expressed in recombinant Escherichia coli (1986) (104)
- Phage display of intact domains at high copy number: A system based on SOC, the small outer capsid protein of bacteriophage T4 (1996) (101)
- Production of Recombinant Proteins (2002) (98)
- BACH2 immunodeficiency illustrates an association between super-enhancers and haploinsufficiency (2017) (96)
- Regulation of HIV-1 protease activity through cysteine modification. (1996) (95)
- Using Amide 1H and 15N Transverse Relaxation To Detect Millisecond Time-Scale Motions in Perdeuterated Proteins: Application to HIV-1 Protease (1998) (92)
- Dissociation of Heparan Sulfate and Receptor Binding Domains of Hepatocyte Growth Factor Reveals That Heparan Sulfate-c-Met Interaction Facilitates Signaling* (2001) (92)
- N-terminal methionine-specific peptidase in Salmonella typhimurium. (1987) (91)
- Four-Dimensional 15N-Separated NOESY of Slowly Tumbling Perdeuterated 15N-Enriched Proteins. Application to HIV-1 Nef (1995) (90)
- Measurement of 3hJNC′ connectivities across hydrogen bonds in a 30 kDa protein (1999) (89)
- The morphogenic linker peptide of HBV capsid protein forms a mobile array on the interior surface (2002) (84)
- Structure, assembly, and antigenicity of hepatitis B virus capsid proteins. (2005) (81)
- Solution Structure of Anti-HIV-1 and Anti-Tumor Protein MAP30 Structural Insights into Its Multiple Functions (1999) (76)
- Preparation and Extraction of Insoluble (Inclusion‐Body) Proteins from Escherichia coli (2012) (73)
- Activator Gcn4 Employs Multiple Segments of Med15/Gal11, Including the KIX Domain, to Recruit Mediator to Target Genes in Vivo*♦ (2009) (70)
- Biophysical and enzymatic properties of the catalytic domain of HIV-1 integrase. (1994) (68)
- The UL36 Tegument Protein of Herpes Simplex Virus 1 Has a Composite Binding Site at the Capsid Vertices (2012) (67)
- N‐Terminal Methionine Processing (2017) (67)
- Three‐dimensional solution structure of the HIV‐1 protease complexed with DMP323, a novel cyclic urea‐type inhibitor, determined by nuclear magnetic resonance spectroscopy (1996) (65)
- HIV-2 protease is inactivated after oxidation at the dimer interface and activity can be partly restored with methionine sulphoxide reductase. (2000) (64)
- Studies on the solution conformation of human thioredoxin using heteronuclear 15N-1H nuclear magnetic resonance spectroscopy. (1990) (62)
- Analysis of the backbone dynamics of the ribonuclease H domain of the human immunodeficiency virus reverse transcriptase using 15N relaxation measurements. (1992) (61)
- Membrane crystals of ubiquinone:cytochrome c reductase from Neurospora mitochondria (1979) (61)
- SIMULTANEOUS MEASUREMENT OF 1H-15N, 1H-13C', AND 15N-13C' DIPOLAR COUPLINGS IN A PERDEUTERATED 30 KDA PROTEIN DISSOLVED IN A DILUTE LIQUID CRYSTALLINE PHASE (1998) (59)
- The solution structure of the N-terminal domain of hepatocyte growth factor reveals a potential heparin-binding site. (1998) (58)
- Antigenic switching of hepatitis B virus by alternative dimerization of the capsid protein. (2013) (58)
- Determination of the secondary structure and molecular topology of interleukin-1 beta by use of two- and three-dimensional heteronuclear 15N-1H NMR spectroscopy. (1990) (58)
- Internal dynamics of the homotrimeric HIV-1 viral coat protein gp41 on multiple time scales. (2013) (58)
- Peptides Corresponding to the Heptad Repeat Motifs in the Transmembrane Protein (gp41) of Human Immunodeficiency Virus Type 1 Elicit Antibodies to Receptor-Activated Conformations of the Envelope Glycoprotein (2001) (58)
- Proteolytic Processing of HIV-1 Protease Precursor, Kinetics and Mechanism* (1999) (58)
- Rabbit IL-1. Cloning, expression, biologic properties, and transcription during endotoxemia. (1989) (57)
- Identification and dynamics of a heparin-binding site in hepatocyte growth factor. (1999) (56)
- Subunit exchange rates in Hepatitis B virus capsids are geometry- and temperature-dependent. (2010) (54)
- The G18V CRYGS mutation associated with human cataracts increases gammaS-crystallin sensitivity to thermal and chemical stress. (2009) (54)
- An easy way to include weak alignment constraints into NMR structure calculations (2001) (54)
- Functional and biophysical characterization of recombinant human hepatocyte growth factor isoforms produced in Escherichia coli. (1997) (53)
- Human Immunodeficiency Virus Rev Protein Recognizes a Target Sequence in Rev-Responsive Element RNA within the Context of RNA Secondary Structure (1992) (53)
- NMR Evidence for the Displacement of a Conserved Interior Water Molecule in HIV Protease by a Non-Peptide Cyclic Urea-Based Inhibitor (1994) (52)
- Biochemical and biological comparison of HIV-1 NEF and ras gene products. (1991) (51)
- The conformation and stability of recombinant-derived granulocyte-macrophage colony stimulating factors. (1988) (50)
- C-terminal peptide identification by fast atom bombardment mass spectrometry. (1988) (49)
- The extracellular domain of immunodeficiency virus gp41 protein: Expression in Escherichia coli, purification, and crystallization (1997) (49)
- Association properties of betaB2- and betaA3-crystallin: ability to form dimers. (1997) (49)
- Reversible Oxidative Modification as a Mechanism for Regulating Retroviral Protease Dimerization and Activation (2003) (48)
- HIV-1 Rev Depolymerizes Microtubules to Form Stable Bilayered Rings (2000) (48)
- Point mutations of human interleukin‐1 with decreased receptor binding affinity (1986) (47)
- Protein Precipitation Using Ammonium Sulfate (2016) (47)
- β-Crystallin association (2004) (46)
- Conformation, stability, and folding of interleukin 1 beta. (1987) (45)
- Enzymology of ubiquinone-utilizing electron transfer complexes in nonionic detergent. (1979) (43)
- Bound Water Molecules at the Interface between the HIV-1 Protease and a Potent Inhibitor, KNI-272, Determined by NMR (1996) (43)
- Determination of solvent content in cavities in IL-1β using experimentally phased electron density (2006) (42)
- Z-disc-associated, Alternatively Spliced, PDZ Motif-containing Protein (ZASP) Mutations in the Actin-binding Domain Cause Disruption of Skeletal Muscle Actin Filaments in Myofibrillar Myopathy* (2014) (42)
- Flexibility and Function in HIV Protease: Dynamics of the HIV-1 Protease Bound to the Asymmetric Inhibitor Kynostatin 272 (KNI-272) (1998) (41)
- Monomer‐trimer equilibrium of the ectodomain of SIV gp41: Insight into the mechanism of peptide inhibition of HIV infection (1999) (41)
- Construction of an enzymatically active ribonuclease H domain of human immunodeficiency virus type 1 reverse transcriptase. (1994) (41)
- Determination of the positions of bound water molecules in the solution structure of reduced human thioredoxin by heteronuclear three-dimensional nuclear magnetic resonance spectroscopy. (1991) (41)
- Long‐range 15N‐1H correlation as an aid to sequential proton resonance assignment of proteins Application to the DNA‐binding protein ner from phage Mu (1988) (41)
- Purification and characterization of the RNase H domain of HIV‐1 reverse transcriptase expressed in recombinant Escherichia coli (1990) (40)
- Assignment of the side-chain 1H and 13C resonances of interleukin-1 beta using double- and triple-resonance heteronuclear three-dimensional NMR spectroscopy. (1990) (39)
- Tumor necrosis factor inhibitor: purification, NH2−terminal amino acidsequence and evidence for anti‐inflammatory and immunomodulatory activities (1990) (38)
- Preparation and characterization of human interleukin-5 expressed in recombinant Escherichia coli. (1990) (37)
- Determination of the secondary structure and global topology of the 44 kDa ectodomain of gp41 of the simian immunodeficiency virus by multidimensional nuclear magnetic resonance spectroscopy. (1997) (36)
- Oculocutaneous albinism type 1: link between mutations, tyrosinase conformational stability, and enzymatic activity (2017) (36)
- Recombinant-derived interleukin-1α stabilized against specific deamidation (1987) (36)
- Mapping hydration water molecules in the HIV-1 protease/DMP323 complex in solution by NMR spectroscopy. (1996) (35)
- Structure and Dynamics of Micelle-Associated Human Immunodeficiency Virus gp 41 Fusion Domain † (2009) (35)
- Characterization of human and mouse granulocyte-macrophage-colony-stimulating factors derived from Escherichia coli. (1987) (35)
- Folding and Purification of Insoluble (Inclusion Body) Proteins from Escherichia coli (2014) (34)
- Epitope-distal effects accompany the binding of two distinct antibodies to hepatitis B virus capsids. (2013) (34)
- Inhibition of HIV-1 replication by a peptide dimerization inhibitor of HIV-1 protease. (2006) (34)
- Albinism-Causing Mutations in Recombinant Human Tyrosinase Alter Intrinsic Enzymatic Activity (2014) (32)
- Determination of the secondary structure of the DNA binding protein Ner from phage Mu using 1H homonuclear and 15N-1H heteronuclear NMR spectroscopy. (1989) (31)
- Purification and characterization of human interleukin‐1α produced in Escherichia coli (1987) (31)
- Sizing up large protein complexes by electrospray ionisation-based electrophoretic mobility and native mass spectrometry: morphology selective binding of Fabs to hepatitis B virus capsids (2013) (30)
- Preparation and characterization of bovine growth hormones produced in recombinant Escherichia coli. (1987) (30)
- Purification and characterization of a methionine-specific aminopeptidase from Salmonella typhimurium. (1989) (30)
- Purification and characterization of the DNA-binding protein Ner of bacteriophage Mu. (1988) (30)
- Epitope diversity of hepatitis B virus capsids: quasi-equivalent variations in spike epitopes and binding of different antibodies to the same epitope. (2006) (30)
- Biophysical Characterization of gp41 Aggregates Suggests a Model for the Molecular Mechanism of HIV-associated Neurological Damage and Dementia* (2000) (30)
- P2′ Benzene Carboxylic Acid Moiety Is Associated with Decrease in Cellular Uptake: Evaluation of Novel Nonpeptidic HIV-1 Protease Inhibitors Containing P2 bis-Tetrahydrofuran Moiety (2013) (29)
- Monomer-dimer equilibrium of normal and modified beta A3-crystallins: experimental determination and molecular modeling. (2000) (29)
- A 1H‐NMR study of human interleukin‐1β (1986) (29)
- Energetics of domain-domain interactions and entropy driven association of beta-crystallins. (2004) (29)
- Native cytokines do not bind to uromodulin (Tamm‐Horsfall glycoprotein) (1988) (29)
- Secondary structure of the ribonuclease H domain of the human immunodeficiency virus reverse transcriptase in solution using three-dimensional double and triple resonance heteronuclear magnetic resonance spectroscopy. (1991) (28)
- Generation and characterization of a chimeric rabbit/human Fab for co-crystallization of HIV-1 Rev. (2010) (28)
- Folding and Purification of Insoluble (Inclusion Body) Proteins from Escherichia coli (1995) (27)
- A recombinant Chinese hamster ovary cell line containing a 300-fold amplified tetramer of the hepatitis B genome together with a double selection marker expresses high levels of viral protein. (1986) (26)
- Characterization of recombinant-derived granulocyte-colony stimulating factor (G-CSF). (1988) (26)
- Human Immunodeficiency Virus (HIV) gp41 Escape Mutants: Cross-Resistance to Peptide Inhibitors of HIV Fusion and Altered Receptor Activation of gp120 (2005) (25)
- Nucleolar protein B23: bacterial expression, purification, oligomerization and secondary structures of two isoforms. (1993) (24)
- Spectroscopic Evidence for a Common Electron Transfer Pathway for Two Tryptophan Tryptophylquinone Enzymes (*) (1995) (24)
- Assessment of differences in the conformational flexibility of hepatitis B virus core‐antigen and e‐antigen by hydrogen deuterium exchange‐mass spectrometry (2014) (23)
- Association properties of betaB1- and betaA3-crystallins: ability to form heterotetramers. (2008) (23)
- Preparation, characterization and application of interleukin-1 beta mutant proteins with surface-accessible cysteine residues. (1989) (22)
- Shared motifs of the capsid proteins of hepadnaviruses and retroviruses suggest a common evolutionary origin (1998) (22)
- N-terminal extension of beta B1-crystallin: identification of a critical region that modulates protein interaction with beta A3-crystallin. (2009) (22)
- Identification and localization of bound internal water in the solution structure of interleukin 1 beta by heteronuclear three-dimensional 1H rotating-frame Overhauser 15N-1H multiple quantum coherence NMR spectroscopy. (1990) (22)
- Human interleukin‐5 expressed in Escherichia coli: assignment of the disulfide bridges of the purified unglycosylated protein (1991) (21)
- Structural biophysics of the NusB:NusE antitermination complex. (2008) (21)
- Specificity of an anti-capsid antibody associated with Hepatitis B Virus-related acute liver failure. (2013) (21)
- Role of the propeptide in controlling conformation and assembly state of hepatitis B virus e-antigen. (2011) (21)
- Molecular basis for the high degree of antigenic cross-reactivity between hepatitis B virus capsids (HBcAg) and dimeric capsid-related protein (HBeAg): insights into the enigmatic nature of the e-antigen. (2010) (21)
- Non-canonical binding of an antibody resembling a naïve B cell receptor immunoglobulin to hepatitis B virus capsids. (2008) (21)
- A proton nuclear magnetic resonance assignment and secondary structure determination of recombinant human thioredoxin. (1989) (21)
- Determination of the contributions of individual aromatic residues to the CD spectrum of IL-1 beta using site directed mutagenesis. (2009) (20)
- Low resolution structure of interleukin-1 beta in solution derived from 1H-15N heteronuclear three-dimensional nuclear magnetic resonance spectroscopy. (1990) (20)
- Use of Protein Folding Reagents (2016) (20)
- N‐terminal‐methionylated interleukin‐1β has reduced receptor‐binding affinity (1987) (19)
- Is human thioredoxin monomeric or dimeric? (2008) (19)
- Secondary structure and signal assignments of human-immunodeficiency-virus-1 protease complexed to a novel, structure-based inhibitor. (1994) (19)
- Evidence that high mannose glycopeptides are able to functionally interact with recombinant tumor necrosis factor and recombinant interleukin 1. (1990) (19)
- A Cell-penetrating Antibody Fragment against HIV-1 Rev Has High Antiviral Activity (2014) (19)
- The Structure of HIV-1 Rev Filaments Suggests a Bilateral Model for Rev-RRE Assembly. (2016) (18)
- Thermodynamic Analysis of Weak Protein Interactions Using Sedimentation Equilibrium (2014) (18)
- The structure of the transcriptional antiterminator NusB from Escherichia coli (2000) (17)
- Sequence specificity in the higher-order interaction of the Rev protein of HIV-1 with its target sequence, the RRE. (1995) (17)
- Chromatofocusing of N-terminally processed forms of proteins. Isolation and characterization of two forms of interleukin-1 beta and of bovine growth hormone. (1987) (17)
- Overview of the Purification of Recombinant Proteins Produced in Escherichia coli (2002) (17)
- Preparation of Soluble Proteins from Escherichia coli (2005) (17)
- Analysis and characterization of dimerization inhibition of a multi-drug-resistant human immunodeficiency virus type 1 protease using a novel size-exclusion chromatographic approach. (2009) (17)
- HIV-1 envelope protein gp41: an NMR study of dodecyl phosphocholine embedded gp41 reveals a dynamic prefusion intermediate conformation. (2014) (17)
- The TYRP1‐mediated protection of human tyrosinase activity does not involve stable interactions of tyrosinase domains (2019) (17)
- Increased sensitivity of amino-arm truncated betaA3-crystallin to UV-light-induced photoaggregation. (2005) (16)
- 3D NMR experiments for measuring 15N relaxation data of large proteins: application to the 44 kDa ectodomain of SIV gp41. (1998) (16)
- A Conserved Hydrogen-Bonding Network of P2 bis-Tetrahydrofuran-Containing HIV-1 Protease Inhibitors (PIs) with a Protease Active-Site Amino Acid Backbone Aids in Their Activity against PI-Resistant HIV (2014) (16)
- The Initial Step in Human Immunodeficiency Virus Type 1 GagProPol Processing Can Be Regulated by Reversible Oxidation (2010) (14)
- Beta-crystallin association. (2004) (14)
- Preparation and Extraction of Insoluble (Inclusion‐Body) Proteins from Escherichia coli (1995) (13)
- Beta-crystallin association. (2004) (13)
- Membrane-associated human tyrosinase is an enzymatically active monomeric glycoprotein (2018) (13)
- Purification of Recombinant Human Tyrosinase from Insect Larvae Infected with the Baculovirus Vector. (2017) (12)
- Purification of Recombinant Proteins (2002) (12)
- Structure of an RNA Aptamer that Can Inhibit HIV-1 by Blocking Rev-Cognate RNA (RRE) Binding and Rev-Rev Association. (2018) (12)
- DETERMINATION OF THE RATE OF MONOMER INTERCHANGE IN A LIGAND-BOUND HOMODIMERIC PROTEIN FROM NOESY CROSS PEAKS : APPLICATION TO THE HIV PROTEASE/KNI-52 9 COMPLEX (1999) (12)
- Cryo-EM study of Hepatitis B virus core antigen capsids decorated with antibodies from a human patient. (2012) (11)
- Site directed mutants of human interleukin‐1α: A 1H‐NMR and receptor binding study (1988) (10)
- A new HIV-1 Rev structure optimizes interaction with target RNA (RRE) for nuclear export. (2018) (10)
- Regulation of the Dimerization and Activity of SARS-CoV-2 Main Protease through Reversible Glutathionylation of Cysteine 300 (2021) (10)
- Purification and characterization of human interleukin-1 beta expressed in recombinant Escherichia coli. (1986) (10)
- Structures of Hepatitis B Virus Core- and e-Antigen Immune Complexes Suggest Multi-point Inhibition. (2018) (10)
- Protein Stability and Functional Characterization of Intra-Melanosomal Domain of Human Recombinant Tyrosinase-Related Protein 1 (2020) (8)
- The structure of the transcriptional antiterminator NusB from Escherichia coli. (2000) (8)
- Preparation of Soluble Proteins from Escherichia coli (1995) (8)
- Structure and partial amino acid sequence of calf thymus DNA topoisomerase II: comparison with other type II enzymes. (1990) (7)
- βB1-Crystallin: Thermodynamic Profiles of Molecular Interactions (2012) (7)
- Expression of quasi-equivalence and capsid dimorphism in the Hepadnaviridae (2020) (7)
- Expression and Purification of ZASP Subdomains and Clinically Important Isoforms: High-Affinity Binding to G-Actin. (2017) (7)
- Development of a novel, pan-variant aerosol intervention for COVID-19 (2021) (6)
- THE CRYSTAL STRUCTURE OF THE SIV GP41 ECTODOMAIN AT 1.47 A (1999) (6)
- Conformational changes in tubulin upon binding cryptophycin-52 reveal its mechanism of action (2021) (6)
- Use of Protein Folding Reagents (1995) (6)
- Overview of the Characterization of Recombinant Proteins (1995) (6)
- Structural characterization of the Myxococcusxanthus encapsulin and ferritin-like cargo system gives insight into its iron storage mechanism. (2022) (6)
- Development of an aerosol intervention for COVID-19 disease: Tolerability of soluble ACE2 (APN01) administered via nebulizer (2022) (6)
- Association properties of β B 2-and β A 3-crystallin : ability to form dimers (1998) (6)
- Cloning and nucleotide sequence of the Salmonella typhimurium pepM gene (1990) (6)
- HIV‐1 gp41 transmembrane oligomerization monitored by FRET and FCS (2018) (5)
- Chimeric rabbit/human Fab antibodies against the hepatitis Be-antigen and their potential applications in assays, characterization, and therapy (2017) (5)
- The state of the N-terminus of recombinant proteins: determination of N-terminal methionine (formylated, acetylated, or free). (1987) (5)
- Pyruvic acid is attached through its central carbon atom to the amino terminus of the recombinant DNA-derived DNA-binding protein Ner of bacteriophage Mu. (1992) (5)
- Purification and characterization of 5-ketofructose reductase from Erwinia citreus. (1988) (5)
- Identification of Protein Interactions (2001) (4)
- Regulation of the Dimerization and Activity of SARS-CoV-2 Main Protease through Reversible Glutathionylation of Cysteine 300 (2021) (4)
- Purification and characterization of human interleukin-la produced in Escherichia coli (1987) (4)
- NMR Experiments for Measuring 15 N Relaxation Data of Large Proteins : Application to the 44 kDa Ectodomain of SIV gp 41 (1998) (3)
- Analysis of the backbone dynamics of interleukin-1 .beta. using two-dimensional inverse detected heteronuclear nitrogen-15-proton NMR spectroscopy [Erratum to document cited in CA113(9):76266p] (1991) (3)
- Cross-linking of isolated oligomycin-insensitive adenosine triphosphatase from ox heart mitochondria. (1975) (3)
- High-Resolution Three-Dimensional Structure of Interleukin 1 , 6 in Solution by Three-and Four-Dimensional Nuclear Magnetic Resonance Spectroscopy + (2001) (2)
- Purification and characterization of human interleukin-1 alpha produced in Escherichia coli. (1987) (2)
- The polypeptides of the ox heart mitochondrial inner membrane: isolation of the major component. (1975) (2)
- Biochemical estimation of hepatitis B surface antigen in recombinant yeast (1987) (2)
- Recombinant-derived interleukin-1 alpha stabilized against specific deamidation. (1987) (2)
- Different effects of pH on the refolding of proteins (1987) (2)
- Generation and use of antibody fragments for structural studies of proteins refractory to crystallization. (2014) (2)
- Activation of virus uptake through induction of macropinocytosis with a novel polymerizing peptide (2014) (2)
- N-terminal-methionylated interleukin-1 beta has reduced receptor-binding affinity. (1987) (2)
- β-Crystallin association [Experimental Eye Research 79 (2004) 377–383] (2004) (2)
- A 1H-NMR study of human interleukin-1 beta. Sequence-specific assignment of aromatic residues using site-directed mutant proteins. (1986) (2)
- Site directed mutants of human interleukin-1 alpha: a 1H-NMR and receptor binding study. (1988) (2)
- Human Modified Tyrosinase And Two Temperature-Sensitive Mutants Are Soluble Active Enzymes (2012) (1)
- Molecular Functional Studies of HIV-1 REV and NEF Proteins (1991) (1)
- IL-12p35 induces expansion of IL-10 and IL-35-expressing regulatory B cells and ameliorates autoimmune disease (2017) (1)
- Characterization of Recombinant Proteins (2003) (1)
- Molecular basis for the high degree of antigenic cross reactivity between hepatitis B virus capsids (HBcAg) and subunits: Insights into the enigmatic nature of e-antigen (2010) (1)
- Crystal Structure of Hepatitis B Virus e-antigen (2013) (1)
- Preface (2001) (1)
- Capsids of hepatitis B virus e antigen with authentic C termini are stabilized by electrostatic interactions (2019) (1)
- Production of Recombinant Proteins (2007) (1)
- Conserved hydrogen-bonding network of P2 bis-tetrahydrofuran (2014) (1)
- THE FLAME PHOTOMETRIC DETERMINATION OF LITHIUM USING INFRA-RED BARRIER LAYER CELLS (1956) (0)
- Production of Recombinant Proteins (2006) (0)
- Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex with amprenavir (2014) (0)
- Characterization of Recombinant Proteins (2003) (0)
- Production of Recombinant Proteins (2009) (0)
- (Recombinant DNA; phage I pL promoter; c repressor; clear-plaque phenotype; protein processing; protease- deficient Escherichiu coli B ; thermoinducible Ner-mediated immunity; prophage; lysogeny) (1988) (0)
- The Homotrimeric HIV-1 Viral Coat Protein GP41 is Highly Dynamic (2013) (0)
- Crystal structure of wild type HIV-1 protease in complex with non-peptidic inhibitor, GRL007 (2013) (0)
- PDB/EMDB validation report for T = 3 capsid (PDB: 6UI6). (2020) (0)
- Production of Recombinant Proteins (2002) (0)
- Heat–Induced Aggregation and Binding to –Crystallin of Amino–Arm Truncated ßA3–Crystallin (2006) (0)
- ZASP Mutations in Actin-binding Domain Cause Disruption of Skeletal Muscle Actin Filaments in Myofibrillar Myopathy (2014) (0)
- Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex with non-peptidic inhibitor, GRL0519 (2016) (0)
- Two Forms of Hepatitis B Virus Capsid Distinguished by a Handedness-Determination Experiment (2007) (0)
- Main contact page for the Protein Expression Laboratory (2007) (0)
- Homo- and Hetero-Associations of βB1-Crystallin Are Dominated by Enthalpy (2010) (0)
- Main staff members page for the Protein Expression Laboratory (2007) (0)
- Computational alanine scanning interface analysis of T = 4 capsids1. (2020) (0)
- Quantitation of Protein Interactions (2003) (0)
- Single-Molecule Dynamics of a Trimeric Aspartate Transporter (2013) (0)
- HIV Escape From Peptide Fusion Inhibitors (2005) (0)
- Long-range lsN-lH correlation as an aid to sequential proton resonance assignment of proteins Application to the DNA-binding protein ner from phage (2001) (0)
- The N-Terminal Extensions in Homo- and Hetero-Associations of β-Crystallins (2009) (0)
- SOLUTION STRUCTURE OF ESCHERICHIA COLI NUSB (2000) (0)
- Preparation and characterization of bovine growth hormones (2005) (0)
- Hepatitis B core-antigen in complex with Fab e21 (2018) (0)
- Identification of Protein Interactions (2004) (0)
- Comparison of the quality of structures in this study with reference structures. (2020) (0)
- Innentitelbild: Stability and Shape of Hepatitis B Virus Capsids In Vacuo (Angew. Chem. 33/2008) (2008) (0)
- Identification of Protein Interactions (2006) (0)
- Preface (2005) (0)
- Conformational analysis of chain pairs with Dyndom1. (2020) (0)
- Hepatitis B e-antigen in complex with scFv e13 (2018) (0)
- Inside Cover: Stability and Shape of Hepatitis B Virus Capsids In Vacuo (Angew. Chem. Int. Ed. 33/2008) (2008) (0)
- Identification of Protein Interactions (2005) (0)
- PURIFICATION OF A PROTEIN EXPRESSED IN ESCHERICHIA COLI IN A SOLUBLE STATE : INTERLEUKIN 1 β Materials (2005) (0)
- Vive La Différence! Mapping Macromolecular Complexes by Generalized Difference Imaging (2000) (0)
- Quantitation of Protein Interactions (2005) (0)
- Preface (2012) (0)
- HIV-1 NEF (REGULATORY FACTOR), NMR, 40 STRUCTURES (1996) (0)
- X-ray crystal structure of wild type HIV-1 protease in complex with GRL-09510 (2017) (0)
- IL-12p35 single chain subunit antagonizes IL-6 mediated STAT1 and STAT3 activation and prevents expansion of Th17 cells in experimental autoimmune uveitis (CCR1P.246) (2014) (0)
- Crystal structure of wild type HIV-1 protease in complex with non-peptidic inhibitor, GRL008 (2013) (0)
- HBV T=4 149C3A (2019) (0)
- All-atom RMSD (Å) of chain-pairs in select core-antigen structures1. (2020) (0)
- Quantitation of Protein Interactions (2005) (0)
- Identification of Protein Interactions (2007) (0)
- HIV-1 Rev assembly domain (residues 1-69) (2018) (0)
- Filaments in Myofibrillar Myopathy Cause Disruption of Skeletal Muscle Actin Mutations in the Actin-binding Domain PDZ Motif-containing Protein ( ZASP ) Z-disc-associated , Alternatively Spliced , Molecular Bases of Disease : (2014) (0)
- Structure, Dynamics and Interactions of Hiv-1 Protease-Inhibitor Complexes (1995) (0)
- Oculocutaneous albinism Type 1 mutations indicate changes in the recombinant tyrosinase folding and activity. (2015) (0)
- Commentary on the article: Purification and characterization of the Ner repressor of bacteriophage Mu (1989) FEBS Lett. 244, 369–375 G. Kukolj, P.P. Tolias and M.S. DuBow (1989) (0)
- PDB/EMDB validation report for T = 4 capsid (PDB: 6UI7). (2020) (0)
- Crystal structure of wild type HIV-1 protease in complex with darunavir (2013) (0)
- HIV-1 PROTEASE-DMP323 COMPLEX IN SOLUTION, NMR MINIMIZED AVERAGE STRUCTURE (1996) (0)
- Structure of the T=3 Hepatitis B Virus Capsid at 3.6Å Resolution (2013) (0)
- Solution NMR Studies of the HIV-1 Protease/Inhibitor Complex : The HIV-1 Protease Catalytic Aspartyl Side-Chain Carboxyl Groups Have Distinct Protonation States in the Complex Formed with the Asymmetric Inhibitor KNI-272 (1996) (0)
- The consequences of deglycosylation of intra-melanosomal domain of human tyrosinase. (2014) (0)
- Crystal Structure of an anti-HBV e-antigen monoclonal Fab fragment (e6), unbound (2013) (0)
- HAIRPIN LOOP CONTAINING DOMAIN OF HEPATOCYTE GROWTH FACTOR, NMR, MINIMIZED AVERAGE STRUCTURE (1998) (0)
- Identification of Protein Interactions (2001) (0)
- Solution structure of NusB from Aquifex Aeolicus (2008) (0)
- HIV-1 PROTEASE-DMP323 COMPLEX IN SOLUTION, NMR, 28 STRUCTURES (1996) (0)
- HIV-1 Rev NTD dimers with variable crossing angles (2016) (0)
- Specific ComplexofHumanImmunodeficiency VirusType1Rev andNucleolar B23Proteins: Dissociation bytheRev Response Element (1991) (0)
- Purification of Recombinant Proteins (2002) (0)
- THE PARATOPE Activity : CHARACTERIZATION OF against HIV-1 Rev Has High Antiviral A Cell-penetrating Antibody Fragment Protein Structure and Folding : (2014) (0)
- Preparation of Soluble Proteins from Escherichia coli (1995) (0)
- HBV core-antigen related structures in the EMDB and PDB databases1. (2020) (0)
- Antigenic Diversity of the Hepatitis B Virus Capsid (2005) (0)
- STING-SAVI nejm appendix (2015) (0)
- PISA intra-dimer interface analysis of T = 3 and T = 4 capsids. (2020) (0)
- The Tyrp1 protection of human tyrosinase activity do not involve interaction between tyrosinase domains. (2018) (0)
- Identification of Protein Interactions (2006) (0)
- Identification of Protein Interactions (2012) (0)
- Main publications page for the Protein Expression Laboratory (2007) (0)
- Crystal structure of wild type HIV-1 protease in complex with GRL-10413 (2016) (0)
- HBV T=3 149C3A (2019) (0)
- Nucleic Acid Content of HBV Capsids Depends on its CTD-Phosphorylation State (2013) (0)
- Purification and Characterization of Recombinant Human Tyrosinase Related Protein 1 (2017) (0)
- Quantitation of Protein Interactions (2006) (0)
- Protein Expression Laboratory Main Page (2001) (0)
- STING-SAVI Paper NEJM (2015) (0)
- Crystal structure of HIV-1 Rev (residues 1-93)-RNA aptamer complex (2018) (0)
- A Proton Nuclear Magnetic Resonance Assignment and Secondary Structure Determination of Recombinant Human Thioredoxint (2001) (0)
- Computational alanine scanning interface analysis of T = 3 capsids1. (2020) (0)
- Enzymology of Succinate:Ubiquinone Reductase in Detergent Solution and Reconstituted Membranes (1981) (0)
- Solution structure of micelle-bound fusion domain of HIV-1 gp41 (2005) (0)
- Purification and characterization of the reverse transcriptase expressed in recombinant September 1990 RNase H domain of HIV-l Escherichia coli (2001) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Paul T. Wingfield?
Paul T. Wingfield is affiliated with the following schools: